PCLAF and cholangiocarcinoma: Prognostic analysis, which is supported by the GEPIA web service, found that lower expression levels of CDK1, CCNB1, and KIAA0101 have better overall survival in CCA, despite the p-value of >0.05 presenting no statistically significant differences (Fig. 5F).